| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5fdec937a5f1f2a5d0e3bdfe512e6df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87b9d4ab7e2b8c89279df9cfae3c24e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b3a89fee63b555734592f21047c3f6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f53eb5608eed45a6c037e37b14369704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73c03e52c6bb6407394c003189c8c051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c73bfb518df26420219dedc1e16916c |
| publicationDate |
2003-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-10223783-A1 |
| titleOfInvention |
New formulation for parenteral administration of a Na-channel blocker |
| abstract |
The invention relates to a novel formulation containing BIII 890 or one of its pharmaceutically acceptable salts for parenteral use. |
| priorityDate |
2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |